Advanced melanoma: The changing landscape of treatment

Andrew Haydon, Maggie Moore

Research output: Contribution to journalReview ArticleOtherpeer-review

Abstract

Recently developed immunotherapies and targeted therapies have largely replaced chemotherapy for treatment of patients with metastatic and nonresectable melanoma. These new drugs have improved the prognosis for many patients, but GPs need to be aware of their unique toxicities.

Original languageEnglish
Pages (from-to)58-61
Number of pages4
JournalMedicine Today
Volume16
Issue number9
Publication statusPublished - 1 Jan 2015
Externally publishedYes

Cite this